SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-032935
Filing Date
2021-02-09
Accepted
2021-02-09 06:01:52
Documents
3
Period of Report
2021-02-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d112159d8k.htm 8-K 27811
2 EX-3.1 d112159dex31.htm EX-3.1 29298
3 EX-3.2 d112159dex32.htm EX-3.2 156457
  Complete submission text file 0001193125-21-032935.txt   214759
Mailing Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUIT 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 21603789
SIC: 2836 Biological Products, (No Diagnostic Substances)